175 related articles for article (PubMed ID: 2677068)
1. Cyanoacrylate skin surface stripping: an improved approach for distinguishing dysplastic nevi from malignant melanomas.
Piérard GE; Piérard-Franchimont C; Arrese Estrada J; Delvoye P; Henry C; Damseaux M; Lê T; Hermans JF; Letot B; Mélotte P
J Cutan Pathol; 1989 Aug; 16(4):180-2. PubMed ID: 2677068
[TBL] [Abstract][Full Text] [Related]
2. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
Cockerell CJ; Berson DS
Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
[TBL] [Abstract][Full Text] [Related]
3. The presence of dysplastic nevus remnants in malignant melanomas. A population-based study of 551 malignant melanomas.
Hastrup N; Osterlind A; Drzewiecki KT; Hou-Jensen K
Am J Dermatopathol; 1991 Aug; 13(4):378-85. PubMed ID: 1928622
[TBL] [Abstract][Full Text] [Related]
4. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
5. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
6. Melanomas, dysplastic nevi and benign nevi: is dysplastic nevus a non-benign neoplasm?
Yus ES; Simon RS
J Cutan Pathol; 2002 Oct; 29(9):570; author reply 570-1. PubMed ID: 12358817
[No Abstract] [Full Text] [Related]
7. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
Duray PH; Ernstoff MS
Arch Dermatol; 1987 Jan; 123(1):80-4. PubMed ID: 3800426
[TBL] [Abstract][Full Text] [Related]
9. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
10. Precursors to melanoma and their mimics: nevi of special sites.
Elder DE
Mod Pathol; 2006 Feb; 19 Suppl 2():S4-20. PubMed ID: 16446715
[TBL] [Abstract][Full Text] [Related]
11. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
[TBL] [Abstract][Full Text] [Related]
12. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
[TBL] [Abstract][Full Text] [Related]
13. Absence of estrogen receptors in dysplastic nevi and malignant melanoma.
Lecavalier MA; From L; Gaid N
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):242-6. PubMed ID: 2212119
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
15. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of atypical moles (dysplastic nevi) from early melanomas by dermoscopy.
Salopek TG; Kopf AW; Stefanato CM; Vossaert K; Silverman M; Yadav S
Dermatol Clin; 2001 Apr; 19(2):337-45. PubMed ID: 11556242
[TBL] [Abstract][Full Text] [Related]
17. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
[TBL] [Abstract][Full Text] [Related]
18. The histopathology of dysplastic nevi. Continued controversy.
Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
[TBL] [Abstract][Full Text] [Related]
19. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
